BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Weber WA, Ott K. Imaging of esophageal and gastric cancer. Semin Oncol. 2004;31:530-541. [PMID: 15297944 DOI: 10.1053/j.seminoncol.2004.04.016] [Cited by in Crossref: 55] [Cited by in F6Publishing: 41] [Article Influence: 3.2] [Reference Citation Analysis]
Number Citing Articles
1 Mcloughlin JM, Melis M, Siegel EM, Dean EM, Weber JM, Chern J, Elliott M, Kelley ST, Karl RC. Are Patients with Esophageal Cancer Who Become PET Negative after Neoadjuvant Chemoradiation Free of Cancer? Journal of the American College of Surgeons 2008;206:879-86. [DOI: 10.1016/j.jamcollsurg.2007.12.027] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 2.6] [Reference Citation Analysis]
2 Mocellin S, Marchet A, Nitti D. EUS for the staging of gastric cancer: a meta-analysis. Gastrointest Endosc. 2011;73:1122-1134. [PMID: 21444080 DOI: 10.1016/j.gie.2011.01.030] [Cited by in Crossref: 74] [Cited by in F6Publishing: 60] [Article Influence: 7.4] [Reference Citation Analysis]
3 Zhu X, Li J. Gastric carcinoma in China: Current status and future perspectives (Review). Oncol Lett 2010;1:407-12. [PMID: 22966316 DOI: 10.3892/ol_00000071] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 2.9] [Reference Citation Analysis]
4 Zhang CD, Ning FL, Zeng XT, Dai DQ. Lymphovascular invasion as a predictor for lymph node metastasis and a prognostic factor in gastric cancer patients under 70 years of age: A retrospective analysis. Int J Surg 2018;53:214-20. [PMID: 29609047 DOI: 10.1016/j.ijsu.2018.03.073] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
5 Li S, Zhao Z, Yang H, Wang D, Sun W, Li S, Zhang Z, Fu W. Construction and Validation of a Nomogram for the Preoperative Prediction of Lymph Node Metastasis in Gastric Cancer. Cancer Control 2021;28:10732748211027160. [PMID: 34155937 DOI: 10.1177/10732748211027160] [Reference Citation Analysis]
6 Allen-Auerbach M, Weber WA. Measuring response with FDG-PET: methodological aspects. Oncologist 2009;14:369-77. [PMID: 19357228 DOI: 10.1634/theoncologist.2008-0119] [Cited by in Crossref: 51] [Cited by in F6Publishing: 37] [Article Influence: 4.3] [Reference Citation Analysis]
7 Park S, Ha S, Kwon HW, Kim WH, Kim TY, Oh DY, Cheon GJ, Bang YJ. Prospective Evaluation of Changes in Tumor Size and Tumor Metabolism in Patients with Advanced Gastric Cancer Undergoing Chemotherapy: Association and Clinical Implication. J Nucl Med. 2017;58:899-904. [PMID: 28572288 DOI: 10.2967/jnumed.116.182675] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 2.4] [Reference Citation Analysis]
8 D'Angelo G, Di Rienzo T, Ojetti V. Microarray analysis in gastric cancer: a review. World J Gastroenterol 2014;20:11972-6. [PMID: 25232233 DOI: 10.3748/wjg.v20.i34.11972] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
9 Xiong B, Cheng Y, Ma L, Zhang C. An Updated Meta-Analysis of Randomized Controlled Trial Assessing the Effect of Neoadjuvant Chemotherapy in Advanced Gastric Cancer. Cancer Investigation 2014;32:272-84. [DOI: 10.3109/07357907.2014.911877] [Cited by in Crossref: 40] [Cited by in F6Publishing: 33] [Article Influence: 5.7] [Reference Citation Analysis]
10 Erasmus JJ, Munden RF. The role of integrated computed tomography positron-emission tomography in esophageal cancer: staging and assessment of therapeutic response. Semin Radiat Oncol. 2007;17:29-37. [PMID: 17185195 DOI: 10.1016/j.semradonc.2006.09.005] [Cited by in Crossref: 34] [Cited by in F6Publishing: 20] [Article Influence: 2.4] [Reference Citation Analysis]
11 Kim TJ, Kim HY, Lee KW, Kim MS. Multimodality assessment of esophageal cancer: preoperative staging and monitoring of response to therapy. Radiographics. 2009;29:403-421. [PMID: 19325056 DOI: 10.1148/rg.292085106] [Cited by in Crossref: 106] [Cited by in F6Publishing: 64] [Article Influence: 8.8] [Reference Citation Analysis]
12 Kwon RS, Sahani DV, Brugge WR. Gastrointestinal cancer imaging: deeper than the eye can see. Gastroenterology. 2005;128:1538-1553. [PMID: 15887150 DOI: 10.1053/j.gastro.2005.03.034] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
13 D’Journo XB, Thomas PA. Current management of esophageal cancer. J Thorac Dis. 2014;6 Suppl 2:S253-S264. [PMID: 24868443 DOI: 10.3978/j.issn.2072-1439.2014.04.16] [Cited by in F6Publishing: 47] [Reference Citation Analysis]
14 Lee JH, Ryu KW, Kim CG, Kim SK, Lee JS, Kook MC, Choi IJ, Kim YW, Chang HJ, Bae JM. Sentinel node biopsy using dye and isotope double tracers in early gastric cancer. Ann Surg Oncol. 2006;13:1168-1174. [PMID: 16924376 DOI: 10.1245/s10434-006-9038-4] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 2.3] [Reference Citation Analysis]
15 Malibari N, Hickeson M, Lisbona R. PET/Computed Tomography in the Diagnosis and Staging of Gastric Cancers. PET Clin. 2015;10:311-326. [PMID: 26099669 DOI: 10.1016/j.cpet.2015.03.008] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
16 Cordin J, Lehmann K, Schneider PM. Clinical Staging of Adenocarcinoma of the Esophagogastric Junction. In: Schneider PM, editor. Adenocarcinoma of the Esophagogastric Junction. Berlin: Springer Berlin Heidelberg; 2010. pp. 73-83. [DOI: 10.1007/978-3-540-70579-6_6] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
17 Weber WA, Wieder H. Monitoring chemotherapy and radiotherapy of solid tumors. Eur J Nucl Med Mol Imaging 2006;33:27-37. [DOI: 10.1007/s00259-006-0133-3] [Cited by in Crossref: 87] [Cited by in F6Publishing: 73] [Article Influence: 5.8] [Reference Citation Analysis]
18 Godoy MCB, Bruzzi JF, Viswanathan C, Truong MT, Guimarães MD, Hofstetter WL, Erasmus JJ, Marom EM. Multimodality imaging evaluation of esophageal cancer: staging, therapy assessment, and complications. Abdom Imaging 2013;38:974-93. [DOI: 10.1007/s00261-013-9986-7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
19 Sweed MR, Edmonson D, Cohen SJ. Tumors of the esophagus, gastroesophageal junction, and stomach. Semin Oncol Nurs 2009;25:61-75. [PMID: 19217506 DOI: 10.1016/j.soncn.2008.10.005] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
20 Kim JH, Chung HS, Youn YH, Park SW, Song SY, Chung JB, Kim CB, Lee YC. Treatment outcomes of 70 cases of early esophageal carcinoma: 12 years of experience. Dis Esophagus 2007;20:297-300. [PMID: 17617877 DOI: 10.1111/j.1442-2050.2007.00674.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
21 Ojetti V, Persiani R, Cananzi FC, Sensi C, Piscaglia AC, Saulnier N, Biondi A, Gasbarrini A, D'Ugo D. cDNA-microarray analysis as a new tool to predict lymph node metastasis in gastric cancer. World J Surg. 2014;38:2058-2064. [PMID: 24696059 DOI: 10.1007/s00268-014-2529-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
22 Reske SN, Deisenhofer S. Is 3′-deoxy-3′-18F-fluorothymidine a better marker for tumour response than 18F-fluorodeoxyglucose? Eur J Nucl Med Mol Imaging 2006;33:38-43. [DOI: 10.1007/s00259-006-0134-2] [Cited by in Crossref: 25] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
23 Gore RM. Endoscopic Ultrasound. Textbook of Gastrointestinal Radiology. Elsevier; 2008. pp. 167-72. [DOI: 10.1016/b978-1-4160-2332-6.50018-x] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
24 Filik M, Kir KM, Aksel B, Soyda Ç, Özkan E, Küçük ÖN, İbiş E, Akgül H. The Role of 18F-FDG PET/CT in the Primary Staging of Gastric Cancer. Mol Imaging Radionucl Ther 2015;24:15-20. [PMID: 25800593 DOI: 10.4274/mirt.26349] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
25 Gallerani G, Fabbri F. Circulating Tumor Cells in the Adenocarcinoma of the Esophagus. Int J Mol Sci 2016;17:E1266. [PMID: 27527155 DOI: 10.3390/ijms17081266] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
26 Bruzzi JF, Truong MT, Macapinlac H, Munden RF, Erasmus JJ. Integrated CT-PET imaging of esophageal cancer: unexpected and unusual distribution of distant organ metastases. Curr Probl Diagn Radiol. 2007;36:21-29. [PMID: 17198889 DOI: 10.1067/j.cpradiol.2006.10.004] [Cited by in Crossref: 28] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
27 Zhu Y, Fu L, Jing W, Guo D, Chen Y, Kong L, Yu J. The value of magnetic resonance imaging in esophageal carcinoma: Tool or toy? Asia‐Pac J Clin Oncol 2019;15:101-7. [DOI: 10.1111/ajco.13112] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
28 Hopkins S, Yang GY. FDG PET imaging in the staging and management of gastric cancer. J Gastrointest Oncol. 2011;2:39-44. [PMID: 22811826 DOI: 10.3978/j.issn.2078-6891.2010.004] [Cited by in F6Publishing: 13] [Reference Citation Analysis]
29 Mizrak Kaya D, Nogueras-González GM, Harada K, Amlashi FG, Roy-Chowdhuri S, Estrella JS, Das P, Lee JH, Weston B, Bhutani MS, Matamoros A Jr, Thomas I, Lin Q, Badgwell BD, Ajani JA. Risk of peritoneal metastases in patients who had negative peritoneal staging and received therapy for localized gastric adenocarcinoma. J Surg Oncol 2018;117:678-84. [PMID: 29205363 DOI: 10.1002/jso.24912] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
30 Gulec SA, Daghighian F, Essner R. PET-Probe: Evaluation of Technical Performance and Clinical Utility of a Handheld High-Energy Gamma Probe in Oncologic Surgery. Ann Surg Oncol 2016;23:9020-7. [PMID: 16865592 DOI: 10.1245/ASO.2006.05.047] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 1.7] [Reference Citation Analysis]
31 Lin J, Kligerman S, Goel R, Sajedi P, Suntharalingam M, Chuong MD. State-of-the-art molecular imaging in esophageal cancer management: implications for diagnosis, prognosis, and treatment. J Gastrointest Oncol 2015;6:3-19. [PMID: 25642333 DOI: 10.3978/j.issn.2078-6891.2014.062] [Cited by in F6Publishing: 9] [Reference Citation Analysis]
32 Varghese TK Jr, Hofstetter WL, Rizk NP, Low DE, Darling GE, Watson TJ, Mitchell JD, Krasna MJ. The society of thoracic surgeons guidelines on the diagnosis and staging of patients with esophageal cancer. Ann Thorac Surg. 2013;96:346-356. [PMID: 23752201 DOI: 10.1016/j.athoracsur.2013.02.069] [Cited by in Crossref: 49] [Cited by in F6Publishing: 37] [Article Influence: 6.1] [Reference Citation Analysis]
33 Gore RM. Upper gastrointestinal tract tumours: diagnosis and staging strategies. Cancer Imaging 2005;5:95-8. [PMID: 16154827 DOI: 10.1102/1470-7330.2005.0020] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
34 Low DE. Update on staging and surgical treatment options for esophageal cancer. J Gastrointest Surg 2011;15:719-29. [PMID: 21487832 DOI: 10.1007/s11605-011-1515-9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
35 van Rossum P, van Lier A, Lips I, Meijer G, Reerink O, van Vulpen M, Lam M, van Hillegersberg R, Ruurda J. Imaging of oesophageal cancer with FDG-PET/CT and MRI. Clinical Radiology 2015;70:81-95. [DOI: 10.1016/j.crad.2014.07.017] [Cited by in Crossref: 39] [Cited by in F6Publishing: 36] [Article Influence: 6.5] [Reference Citation Analysis]
36 Ki SH, Jeong S, Park IS, Lee DH, Lee JI, Kwon KS, Kim HG, Shin YW. Esophageal mucosal metastasis from adenocarcinoma of the distal stomach. World J Gastroenterol 2013;19:3699-702. [PMID: 23801875 DOI: 10.3748/wjg.v19.i23.3699] [Cited by in CrossRef: 1] [Article Influence: 0.1] [Reference Citation Analysis]
37 Power DG, Schattner MA, Gerdes H, Brenner B, Markowitz AJ, Capanu M, Coit DG, Brennan M, Kelsen DP, Shah MA. Endoscopic ultrasound can improve the selection for laparoscopy in patients with localized gastric cancer. J Am Coll Surg. 2009;208:173-178. [PMID: 19228527 DOI: 10.1016/j.jamcollsurg.2008.10.022] [Cited by in Crossref: 58] [Cited by in F6Publishing: 46] [Article Influence: 4.5] [Reference Citation Analysis]
38 Essner R, Belhocine T, Scott AM, Even-sapir E. Novel Imaging Techniques in Melanoma. Surgical Oncology Clinics of North America 2006;15:253-83. [DOI: 10.1016/j.soc.2005.12.009] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
39 Wang QW, Zhang XT, Lu M, Shen L. Impact of duration of adjuvant chemotherapy in radically resected patients with T4bN1-3M0/TxN3bM0 gastric cancer. World J Gastrointest Oncol 2018;10:31-9. [PMID: 29375746 DOI: 10.4251/wjgo.v10.i1.31] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
40 Mocellin S, Pasquali S. Diagnostic accuracy of endoscopic ultrasonography (EUS) for the preoperative locoregional staging of primary gastric cancer. Cochrane Database Syst Rev. 2015;CD009944. [PMID: 25914908 DOI: 10.1002/14651858.cd009944.pub2] [Cited by in Crossref: 51] [Cited by in F6Publishing: 52] [Article Influence: 8.5] [Reference Citation Analysis]
41 Lu J, Sun XD, Yang X, Tang XY, Qin Q, Zhu HC, Cheng HY, Sun XC. Impact of PET/CT on radiation treatment in patients with esophageal cancer: A systematic review. Crit Rev Oncol Hematol 2016;107:128-37. [PMID: 27823640 DOI: 10.1016/j.critrevonc.2016.08.015] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 2.4] [Reference Citation Analysis]